Novo Nordisk (NVO) ROE US GAAP (year values) |
|||||||||
2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
ROE, % | ? | 67.5% | 67.5% | 66.5% | 66.5% | 78.5% | 90.3% | ||
Changes by years, y/y, % | +1pp | 0pp | -1pp | 0pp | +12pp | +1.1% |
Novo Nordisk. ROE, %
Novo Nordisk. ROE, changes, pp
Novo Nordisk (NVO) ROE US GAAP (quarter values) |
||||||||
2025Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
ROE, % | ? | 67.1% | 81.0% | 78.5% | 90.3% | 90.3% | ||
Changes by years, y/y, % | +16pp | +12pp | +12pp | +14pp | ||||
Changes by quarters, q/q, % | -77pp | +14pp | -2pp | +12pp |